MISSOULA, Mont.--(BUSINESS WIRE)-- OSRX, Inc., a leading provider of compounded ophthalmic medications, announced that the company remains fully licensed, fully operational and continues to serve the ...
MISSOULA, Mont.--(BUSINESS WIRE)--OSRX, Inc. today expressed its profound disappointment with the recent jury verdict in the case of ImprimisRx, LLC v. OSRX, Inc. The company believes the decision to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results